Basel, Switzerland

Kathrin Wagner


Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 86(Granted Patents)


Company Filing History:


Years Active: 1998-2000

Loading Chart...
2 patents (USPTO):Explore Patents

Title: **Kathrin Wagner: Pioneering Advances in Chimeric Antibodies**

Introduction

Kathrin Wagner is an innovative inventor based in Basel, Switzerland. She has made significant contributions to the field of biomedical research, particularly through her work on chimeric antibodies. With a total of two patents to her name, her inventions have the potential to impact cancer diagnosis and therapy.

Latest Patents

Wagner's latest patents focus on murine/human chimeric monoclonal antibodies that exhibit high specificity and affinity for the human carcinoembryonic antigen (CEA). These patents describe the processes for preparing these antibodies and their derivatives, as well as the DNAs coding for the heavy and light chains of these antibodies. Furthermore, her inventions include mammalian cell lines that produce and secrete the antibodies, alongside the methodologies for their preparation. The applications of these chimeric antibodies extend to both clinical in vitro and in vivo settings, particularly in cancer diagnosis, tumor localization, and targeted delivery of cytotoxic agents. The invention also encompasses test kits and pharmaceutical compositions that incorporate these chimeric monoclonal antibodies and their derivatives.

Career Highlights

Kathrin Wagner currently works at Ciba-Geigy Corporation, where she contributes to cutting-edge research and development in biotechnology. Her expertise in antibody engineering plays a crucial role in advancing the therapeutic options available for cancer patients.

Collaborations

During her career, Wagner has worked alongside notable colleagues such as Norman Hardman and Laura Lee Gill. This collaborative environment has facilitated the exchange of innovative ideas and has enhanced the effectiveness of their collective research.

Conclusion

Kathrin Wagner stands out as a dedicated inventor whose work in the development of chimeric antibodies can significantly enhance cancer diagnosis and treatment. Through her patents and collaborations, she continues to contribute meaningfully to the field of biomedical research, showing promise for future innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…